Log In
Print
BCIQ
Print
Print this Print this
 

Coartem, artemether/lumefantrine

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionFixed-dose artemisinin-based combination treatment
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today